X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Research & Development

Micromeritics Announces Instrument Grant to the Massachusetts Institute of Technology

Yuvraj_pawp by Yuvraj_pawp
31st March 2015
in Research & Development

Micromeritics’ Instrument Grant Committee has recently selected its latest grant recipient.

A 3Flex Surface Characterisation Analyser was awarded to the Civil and Environmental Engineering Department of MIT.

MIT senior research scientist Dr Roland Pellenq said: “The department aims at determining the poro-mechanical and transport properties of the most important technological, economical and environmental materials in the world: cement and concrete, source rocks for oil and gas, oxide, glasses and clays for nuclear energy and nuclear waste storage.”

The company will use a ‘nanoscope’ method to scrutinise and manipulate materials in a broad range of magnifications.

Pore structure characterisation, including porosity assessment, pore size distribution, and specific surfaces are key factors in their approach and is the reason they applied for the Micromeritics gift award.

Dr Pellenq is one of the co-founders and lead scientist of the Concrete Sustainability Hub, CSH@MIT, an interdisciplinary research centre dedicated to the reduction of the environmental footprint of the cement and concrete industry.

The centre was opened in October 2009.

Dr Pellenq was hired as a MIT senior research scientist in November 2010 and is the director of the CNRS-MIT joint laboratory ‘Multiscale Material Science of Energy and Environment.’

Micromeritics president Preston Hendrix said: “This program is designed to promote and advance the acquisition and use of particle characterisation instrumentation in non-profit universities and institutions where other means of funding are not generally available.”

Mr Hendrix appointed a special Grant Selection Committee to ensure the success and effectiveness of the program.

Micromeritics’ Instrument Grant Program is intended to provide particle characterisation instruments to non-profit universities and research organisations to foster and support meritorious research projects.

A maximum of one instrument / integrated system will be awarded per calendar quarter.

Applications may be submitted anytime in accordance with the application instructions and will remain active for a period of one year from the date of submission.

Visit the Grant Program website for a detailed grant description, application requirements and application.

Previous Post

GSK to provide meningitis B vaccine in UK

Next Post

Novartis's Jadenu receives FDA approval to treat chronic iron overload

Related Posts

Robots and AI in Drug
Articles

Robots and AI in Drug Discovery Are Transforming Medicine

29th May 2025
Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Next in Pharma 2025 Innovations
Articles

Next in Pharma 2025: Innovations Shaping the Future

28th May 2025
Insights

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

27th May 2025
Insights

AstraZeneca Eyes Acquisition To Develop Cell Therapies

24th March 2025
Drug Development

Continuous Bioprocessing Market to Surge by 2028

7th March 2025
Next Post

Perrigo completes acquisition of OTC drugmaker Omega Pharma for $4.5bn

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In